XBIT · XBiotech Inc.

$2.27 -0.03 (-1.30%) At close · Aug 28

Market Cap

$69.21M

30.49M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Simard	President & Chief Executive Officer	$1,205,083	$5,030,000	—	—	—	$10,498	$6,245,581
Sushma Shivaswamy	Chief Scientific Officer	$450,000	$197,047	—	—	—	$10,498	$657,572
Dr. Sushma Shivaswamy	—	$450,000	$197,047	—	—	—	$10,498	$657,572
Angela Hu	Director of Finance	$200,000	$80,000	—	—	—	$5,419	$285,419

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Simard	President & Chief Executive Officer	$1,065,440	$4,480,000	—	—	—	$11,041	$5,556,481
Sushma Shivaswamy	Ph.D. Chief Scientific Officer	$445,190	—	—	$270,509	—	$4,800	$720,499
Dr. Sushma Shivaswamy	—	$445,190	—	—	$270,509	—	$4,800	$720,499
Angela Hu	Director of Finance	$193,333	—	—	$81,153	—	$4,800	$279,286

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Simard	President & Chief Executive Officer	$881,440	$3,780,000	—	—	—	$9,494	$4,670,934
Dr. Sushma Shivaswamy	—	$376,440	—	—	—	—	$4,800	$381,240
Sushma Shivaswamy	Ph.D. Chief Scientific Officer	$376,440	—	—	—	—	$4,800	$381,240
Queena Han	Vice President Finance & HR and Secretary	$322,760	—	—	—	—	$9,494	$332,255

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Simard	President & Chief Executive Officer	$776,598	$7,000,000	—	—	—	$8,955	$7,785,554
Sushma Shivaswamy	Ph.D. Chief Scientific Officer	$376,440	$187,500	—	$875,080	—	$4,800	$1,443,820
Dr. Sushma Shivaswamy	—	$376,440	$187,500	—	$875,080	—	$4,800	$1,443,820
Queena Han	Vice President Finance & HR and Secretary	$321,105	$159,832	—	$306,278	—	$8,955	$796,171

Executive changes

Person	Role	Change	Effective	Filed
Sushma Shivaswamy	interim CEO	Appointed	2025-12-08	2025-12-09
John Simard	President and Chief Executive Officer	Retired	2025-12-08	2025-12-09
Craig Rademaker	Board of Directors	Appointed	2025-06-24	2025-06-24
Thomas Kündig	Board of Directors	Appointed	2025-06-24	2025-06-24
W. Thorpe McKenzie	Board of Directors	Retired	2025-03-27	2025-04-01
Tak W. Mak, Ph.D.	Board of Directors	Appointed	2024-12-24	2024-12-31
Queena Han	Vice President, Finance and Human Resource	Terminated	2023-02-03	2023-02-15
Angela Hu	principal accounting officer	Appointed	2023-02-10	2023-02-15
Angela Hu	principal financial officer	Appointed	2023-02-10	2023-02-15

Key facts CIK 1626878 CUSIP 98400H102 13F (30d) 35 filings 35 filers Visit website Investor relations